Clinical trials
Phase 2 Epilepsy trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2006 | 1 |
| 2010 | 1 |
| 2018 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 3 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eisai Inc. | 2 |
| GlaxoSmithKline | 2 |
| Neurocrine Biosciences | 2 |
| Takeda | 2 |
| Biohaven Therapeutics Ltd. | 1 |
| Engage Therapeutics, Inc. | 1 |
| Longboard Pharmaceuticals | 1 |
| Supernus Pharmaceuticals, Inc. | 1 |
| UCB Biopharma S.P.R.L. | 1 |
| UCB Biopharma SRL | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 14 |
| Seizures | 9 |
| Epilepsies, Myoclonic | 3 |
| Lennox Gastaut Syndrome | 3 |
| Drug Resistant Epilepsy | 2 |
| Tuberous Sclerosis | 2 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Epilepsies, Partial | 1 |
| Hypoxia-Ischemia, Brain | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.